Neuroscience and Psychopharmacology in the Era of COVID19
The pace at which the health and financial consequences of COVID19 have pervaded society has left us in an overwhelming state of stress. Science and medicine have generated theories that normally are tested over time, but the precipitous climb of mortality and morbidity left us scrambling for answers and hanging our hopes on treatments that ultimately proved ineffective or in some cases hazardous. This presentation will parse out the scientific facts from theory regarding neurological sequelae of COVID19 exposure and how medications prescribed for mental health conditions may interact with treatments used for COVID19.
Please join us for a series of webinars exploring topics in Clinical Psychopharmacology. Our featured speaker is Dr. Judith Steinman, PhD. As past-President of APA Division 55 and Program Director for the nation’s first Postdoctoral Master of Science in Clinical Psychopharmacology, Dr. Steinman will share with you her experience in the field and the importance of prescriptive authority for improved behavioral mental health access.
Monday, October 19 at 4:00pmVirtual Event
If you have Alliant.edu email login credentials, please login with your Alliant.edu account.
If you do not have Alliant.edu email credentials, please login using one of the social options below to interact with events, personalize your calendar, and get recommendations.Login with Twitter Login with LinkedIn
If you do not have Alliant.edu email credentials nor a social login, please login with your email address below.